Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

The Word Brain 2015Free PDF | Print | Web
A short guide to fast language learning

Free Abstracts

  Hepatitis

  Free Subscription


10.08.2015

2 AIDS
2 Arch Virol
3 BMC Gastroenterol
1 Clin Infect Dis
1 Dig Dis Sci
1 Gastroenterology
14 Hepatology
1 J Hepatol
2 J Med Virol
1 J Viral Hepat
2 J Virol
2 Lancet
1 Lancet Infect Dis
1 MMWR Recomm Rep
5 PLoS One
1 Vaccine
1 Virology


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    AIDS

  1. ALEMAN J, van den Berk GE, Franssen EJ, de Fijter CW, et al
    Tenofovir disoproxil treatment for a HIV-hepatitis B virus coinfected patient undergoing peritoneal dialysis: which dose do we need?
    AIDS. 2015;29:1579-80.
    PubMed     Text format    

  2. ZAEGEL-FAUCHER O, Bregigeon S, Cano CE, Obry-Roguet V, et al
    Impact of hepatitis C virus coinfection on T-cell dynamics in long-term HIV-suppressors under combined antiretroviral therapy.
    AIDS. 2015;29:1505-10.
    PubMed     Text format     Abstract available


    Arch Virol

  3. GUZMAN-HERRADOR BR, Panning M, Stene-Johansen K, Borgen K, et al
    Importance of molecular typing in confirmation of the source of a national hepatitis A virus outbreak in Norway and the detection of a related cluster in Germany.
    Arch Virol. 2015.
    PubMed     Text format     Abstract available

  4. RUGGIERO T, Proietti A, Boglione L, Milia MG, et al
    Predominance of hepatitis C virus Q80K among NS3 baseline-resistance-associated amino acid variants in direct-antiviral-agent-naive patients with chronic hepatitis: single-centre experience.
    Arch Virol. 2015.
    PubMed     Text format     Abstract available


    BMC Gastroenterol

  5. STEINEBRUNNER N, Sprinzl MF, Zimmermann T, Worns MA, et al
    Early virological response may predict treatment response in sofosbuvir-based combination therapy of chronic hepatitis c in a multi-center "real-life" cohort.
    BMC Gastroenterol. 2015;15:97.
    PubMed     Text format     Abstract available

  6. ZHANG S, Bastian ND, Griffin PM
    Cost-effectiveness of sofosbuvir-based treatments for chronic hepatitis C in the US.
    BMC Gastroenterol. 2015;15:98.
    PubMed     Text format     Abstract available

  7. SIRIWARDANA RC, Niriella MA, Dassanayake AS, Liyanage CA, et al
    Factors affecting post-embolization fever and liver failure after trans-arterial chemo-embolization in a cohort without background infective hepatitis- a prospective analysis.
    BMC Gastroenterol. 2015;15:96.
    PubMed     Text format     Abstract available


    Clin Infect Dis

  8. HEARN B, Chasan R, Bichoupan K, Suprun M, et al
    Low Adherence of HIV Providers to Practice Guidelines for Hepatocellular Carcinoma Screening in HIV/Hepatitis B Co-infection.
    Clin Infect Dis. 2015.
    PubMed     Text format     Abstract available


    Dig Dis Sci

  9. COLOM STEELE D, Mojtahed A, Samedi V, Alcorn J, et al
    "Ferritin Out" a Cause of Acute Hepatitis.
    Dig Dis Sci. 2015.
    PubMed     Text format    


    Gastroenterology

  10. FOSTER GR, Pianko S, Brown A, Forton D, et al
    Efficacy of Sofosbuvir Plus Ribavirin With or Without Peginterferon-alfa in Patients With HCV Genotype 3 Infection and Treatment-Experienced Patients with Cirrhosis and HCV Genotype 2 Infection.
    Gastroenterology. 2015 Aug 3. pii: S0016-5085(15)01069.
    PubMed     Text format     Abstract available


    Hepatology

  11. KANNINEN TT, Dieterich D, Asciutti S
    HCV vertical transmission in pregnancy: New horizons in the era of DAAs.
    Hepatology. 2015 Aug 3. doi: 10.1002/hep.28032.
    PubMed     Text format     Abstract available

  12. FUJITA T, Soontrapa K, Ito Y, Iwaisako K, et al
    Hepatic stellate cells relay inflammation signaling from sinusoids to parenchyma in mouse models of immune-mediated hepatitis.
    Hepatology. 2015 Aug 6. doi: 10.1002/hep.28112.
    PubMed     Text format     Abstract available

  13. PERIN PM, Haid S, Brown RJ, Doerrbecker J, et al
    Flunarizine prevents hepatitis C virus membrane fusion in a genotype-dependent manner by targeting the potential fusion peptide within E1.
    Hepatology. 2015 Aug 6. doi: 10.1002/hep.28111.
    PubMed     Text format     Abstract available

  14. RICE C, Chen Z
    Repurposing an old drug: A low-cost allergy medication provides new hope for hepatitis C patients.
    Hepatology. 2015 Aug 3. doi: 10.1002/hep.28028.
    PubMed     Text format    

  15. GISH RG, Cohen CA, Block JM, Brosgart CL, et al
    Data supporting updating estimates of the prevalence of chronic hepatitis B and C in the United States.
    Hepatology. 2015 Aug 3. doi: 10.1002/hep.28026.
    PubMed     Text format    

  16. LIANG TJ, Block TM, McMahon BJ, Ghany MG, et al
    Present and future therapies of hepatitis B: From discovery to cure.
    Hepatology. 2015 Aug 3. doi: 10.1002/hep.28025.
    PubMed     Text format     Abstract available

  17. YOUNOSSI ZM, Stepanova M, Marcellin P, Afdhal N, et al
    Treatment with ledipasvir and sofosbuvir improves patient-reported outcomes: Results from the ION-1, -2, and -3 clinical trials.
    Hepatology. 2015;61:1798-808.
    PubMed     Text format     Abstract available

  18. SHIBATA S, Umemura T, Komatsu M, Tanaka E, et al
    Severe hepatotoxicity associated with asunaprevir and daclatasvir in chronic hepatitis C.
    Hepatology. 2015 Aug 6. doi: 10.1002/hep.28113.
    PubMed     Text format    

  19. FUJII Y, Uchida Y, Mochida S
    Reply to the Letter Entitled "Severe Hepatotoxicity Associated with Asunaprevir and Daclatasvir in Chronic Hepatitis C".
    Hepatology. 2015 Aug 6. doi: 10.1002/hep.28114.
    PubMed     Text format    

  20. ROBERTS H, Kruszon-Moran D, Ly KN, Hughes E, et al
    Prevalence of chronic hepatitis B virus (HBV) infection in U.S. households - national health and nutrition examination survey (NHANES), 1988-2012.
    Hepatology. 2015 Aug 6. doi: 10.1002/hep.28109.
    PubMed     Text format     Abstract available

  21. KACHKO A, Frey SE, Sirota L, Ray R, et al
    Antibodies to an interfering epitope in hepatitis C Virus E2 can mask vaccine-induced neutralizing activity.
    Hepatology. 2015 Aug 6. doi: 10.1002/hep.28108.
    PubMed     Text format     Abstract available

  22. WANG H, El Maadidi S, Fischer J, Grabski E, et al
    A frequent hypofunctional IRAK2 variant is associated with reduced spontaneous hepatitis C virus clearance.
    Hepatology. 2015 Aug 6. doi: 10.1002/hep.28105.
    PubMed     Text format     Abstract available

  23. TURNER B, Taylor B, Hanson J, Liang Y, et al
    High Priority for Hepatitis C Screening in Safety Net Hospitals: Results from a Prospective Cohort of 4582 Hospitalized Baby Boomers.
    Hepatology. 2015 Aug 6. doi: 10.1002/hep.28018.
    PubMed     Text format     Abstract available

  24. JUNG KS, Kim SU, Song K, Park JY, et al
    Validation of hepatitis B virus-related hepatocellular carcinoma prediction models in the era of antiviral therapy.
    Hepatology. 2015 Aug 6. doi: 10.1002/hep.28115.
    PubMed     Text format     Abstract available


    J Hepatol

  25. HALFON P, Penaranda G, Ouzan D
    A response-guided approach based on HBsAg kinetics may identify patients with the greatest chance of success.
    J Hepatol. 2015;62:238.
    PubMed     Text format    


    J Med Virol

  26. LO G, Sow-Sall A, Diop-Ndiaye H, Mandiouba NC, et al
    Prevalence of hepatitis B markers in Senegalese HIV-1 infected patients.
    J Med Virol. 2015 Aug 7. doi: 10.1002/jmv.24344.
    PubMed     Text format     Abstract available

  27. ZHONG L, Xi G, Zhang L, Liu S, et al
    The estimation of prevalence and risk factors of hepatitis B virus infection among blood donors in Chengdu, China.
    J Med Virol. 2015 Aug 4. doi: 10.1002/jmv.24339.
    PubMed     Text format     Abstract available


    J Viral Hepat

  28. REN F, Shi H, Zhang L, Zhang X, et al
    The dysregulation of endoplasmic reticulum stress response in acute-on-chronic liver failure patients caused by acute exacerbation of chronic hepatitis B.
    J Viral Hepat. 2015 Jul 31. doi: 10.1111/jvh.12438.
    PubMed     Text format     Abstract available


    J Virol

  29. REYNOLDS TD, Buonocore L, Rose NF, Rose JK, et al
    Virus-Like Vesicle-Based Therapeutic Vaccine Vectors for Chronic Hepatitis B Virus Infection.
    J Virol. 2015 Aug 5. pii: JVI.01184.
    PubMed     Text format     Abstract available

  30. FALSON P, Bartosch B, Alsaleh K, Tews BA, et al
    Hepatitis C virus envelope glycoprotein E1 forms trimers at the surface of the virion.
    J Virol. 2015 Aug 5. pii: JVI.00991.
    PubMed     Text format     Abstract available


    Lancet

  31. SCHWEITZER A, Horn J, Mikolajczyk RT, Krause G, et al
    Estimations of worldwide prevalence of chronic hepatitis B virus infection: a systematic review of data published between 1965 and 2013.
    Lancet. 2015 Jul 28. pii: S0140-6736(15)61412.
    PubMed     Text format     Abstract available

  32. MACLACHLAN JH, Locarnini S, Cowie BC
    Estimating the global prevalence of hepatitis B.
    Lancet. 2015 Jul 28. pii: S0140-6736(15)61116.
    PubMed     Text format    


    Lancet Infect Dis

  33. CHEN DS, Locarnini S, Wallace J
    From the big three to the big four.
    Lancet Infect Dis. 2015;15:626-7.
    PubMed     Text format    


    MMWR Recomm Rep

  34. WORKOWSKI KA, Bolan GA
    Sexually transmitted diseases treatment guidelines, 2015.
    MMWR Recomm Rep. 2015;64.
    PubMed     Text format     Abstract available


    PLoS One


  35. Correction: A Lead-In with Silibinin Prior to Triple-Therapy Translates into Favorable Treatment Outcomes in Difficult-To-Treat HIV/Hepatitis C Coinfected Patients.
    PLoS One. 2015;10:e0135547.
    PubMed     Text format     Abstract available

  36. RUDLER M, Mouri S, Charlotte F, Cluzel P, et al
    Validation of AshTest as a Non-Invasive Alternative to Transjugular Liver Biopsy in Patients with Suspected Severe Acute Alcoholic Hepatitis.
    PLoS One. 2015;10:e0134302.
    PubMed     Text format     Abstract available

  37. CHOO MK, El-Bassel N, Adam PC, Gilbert L, et al
    Prevalence and Correlates of HIV and Hepatitis C Virus Infections and Risk Behaviors among Malaysian Fishermen.
    PLoS One. 2015;10:e0118422.
    PubMed     Text format     Abstract available

  38. DOLD L, Ahlenstiel G, Althausen E, Luda C, et al
    Survival and HLA-B*57 in HIV/HCV Co-Infected Patients on Highly Active Antiretroviral Therapy (HAART).
    PLoS One. 2015;10:e0134158.
    PubMed     Text format     Abstract available

  39. ZOU Y, Bao J, Pan X, Lu Y, et al
    NKP30-B7-H6 Interaction Aggravates Hepatocyte Damage through Up-Regulation of Interleukin-32 Expression in Hepatitis B Virus-Related Acute-On-Chronic Liver Failure.
    PLoS One. 2015;10:e0134568.
    PubMed     Text format     Abstract available


    Vaccine

  40. WHO
    Hepatitis E vaccine: WHO position paper, May 2015 - Recommendations.
    Vaccine. 2015 Jul 29. pii: S0264-410X(15)01017.
    PubMed     Text format     Abstract available


    Virology

  41. BOUEZZEDINE F, Fardel O, Gripon P
    Interleukin 6 inhibits HBV entry through NTCP down regulation.
    Virology. 2015;481:34-42.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


All AMEDEO services are free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Amedeo is a Flying Publisher website.

   Design: